Dr Jienchi Dorward is an NIHR Academic Clinical Lecturer in the Nuffield Department of Primary Care Health Sciences at the University of Oxford. His research is based in South Africa and the UK, and focused on the management of infectious diseases in primary care. At Oxford he works in the Infections, Respiratory and Acute Care team and the NIHR HealthTech Research Centre in Community Healthcare.
At CAPRISA, Dr Dorward primarily works with the SHAPE study; a collaboration with South African primary care services which uses de-identified routine data to evaluate the HIV/TB programme. He has served as co-PI or co-Investigator on several randomised controlled trials of point-of-care HIV viral load and point-of-care urine tenofovir adherence tests, including the POwER and PHILA studies, and the US NIH funded STREAM and STREAM-HIV trials. He was also a co-investigator and trial management group member for the PANORAMIC and PRINCIPLE trials, the UK national platform adaptive trials of antivirals and repurposed medications to treat COVID-19 in the community. Dr Dorward has previously worked at CAPRISA as a Research Clinician and Project Manager.
He has completed his UK General Practice (Family Medicine) specialty training through clinical placements in the London Deanery, UK and Bethesda Hospital, South Africa, before doing the MSc in Public Health in Developing Countries at the London School of Hygiene & Tropical Medicine, and then a DPhil in Primary Care at the University of Oxford.